Lai Wang, Global Head of R&D at BeiGene, Ltd. (BGNE), sold 2,126 shares at $159.80 ($340K) on 2024-06-24, disclosed to the SEC on 2024-06-26.
Seasonal sale ($340k) by Global Head of R&D — this insider has traded BGNE in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $159.80 | 1,062 | $170K | 50.0% |
| 2 | $159.80 | 1,062 | $170K | 50.0% |
| 3 | $161.10 | 2 | $322 | 0.1% |
| Total | $159.80 avg | 2,126 | $340K | 100% |
| Filing → |
| ONC | SELL | 2026-06-15 | $197K | — | Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |